US Bancorp’s Dare Bioscience DARE Stock Holding History

US Bancorp’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	120,920 +29,550	+32%	+$66.1K	﹤0.01%	1975
2026 Q1	$166K	Buy	91,370 +70,450	+337%	+$121K	﹤0.01%	2113
2025 Q4	$40.4K	Buy	+20,920	New	+$41.7K	﹤0.01%	2790

Other funds holding DARE

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

US Bancorp's DARE Position: Q2 2026 in Review

US Bancorp increased its Dare Bioscience (DARE) stake by 32% in Q2 2026, buying an estimated $66.1K and bringing the position to 120,920 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

US Bancorp first reported a position in DARE in Q4 2025 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

US Bancorp held 120,920 shares of Dare Bioscience worth $255K as of Q2 2026.
US Bancorp bought 29,550 Dare Bioscience shares in Q2 2026, an estimated $66.1K.
Dare Bioscience made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1975 holding.
US Bancorp first reported a position in Dare Bioscience in Q4 2025 and has held it in 3 quarters since.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.